Business
BD and Penn Institute for Immunology and Immune Health Collaborate to Advance Immunotherapy through Flow Cytometry
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced a strategic collaboration with the Institute for Immunology and Immune Health (I3H) at the University of Pennsylvania, to advance research in deep human immune profiling and support the development of immune-mediated therapies.
About this update from Becton, Dickinson And Company
[{"type":"text","content":"BD FACSDiscover™ A8 Cell Analyzer to Enable Investigation of 30+ Cellular Characteristics to Capture Key Biological Insights and Support Planned 1,000-Person Immune Profiling Study","length":180,"tagName":"p","attribs":{}},{"type":"text","content":"FRANKLIN LAKES, N.J., Dec. 18, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced a strategic collaboration with the Institute for Immunology and Immune Health (I3H) at the University of Pennsylvania, to advance research in deep human immune profiling and support the development of immune-mediated therapies.","length":388,"tagName":"p"},{"type":"image","alt":"BD announces strategic collaboration with the Institute for Immunology and Immune Health (I3H) at the University of Pennsylvania to advance immunotherapy through flow cytometry","displaySize":"","headline":null,"caption":"BD announces strategic collaboration with the Institute for Immunology and Immune Health (I3H) at the University of Pennsylvania to advance immunotherapy through flow cytometry","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":230,"url":"https://media.zenfs.com/en/prnewswire.com/aa839811f1a1ed0d073173e71c7bce40"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/SZl7mMqIHmzr90rq_w.MiA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTQwNTtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/aa839811f1a1ed0d073173e71c7bce40","width":400,"height":230}},"href":"https://mma.prnewswire.com/media/2848148/BD_announces_strategic_collaboration_with_I3H.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"The collaboration includes developing and validating a high-parameter flow cytometry panel that can capture key functional pathways in whole blood, including phosphorylation markers, which provide powerful insight into how single cells respond to drugs or disease states. The panel will support a planned 1,000-patient immune profiling study, in partnership with the Penn Colton Center for Autoimmunity, expected to start this summer. The project will leverage the BD FACSDiscover™ A8 Cell Analyzer, BD Rhapsody™ System, BD reagents, software and informatics, with BD teams managing reagents, instrumentation, and spectral data algorithms, and I3H teams serving as scientific and clinical leads. The team intends t...